For most of a decade, vitamin D came with a warning: take it on its own, and the calcium it raises ends up in your arteries instead of your bones. The fix, supposedly, is vitamin K2. The claim is unusually specific for supplement advice, specific enough to put to randomized, placebo-controlled trials with arterial calcium scored on CT before and after. The trials came back. They don't agree with each other. So what does the evidence actually show, and did a 2026 trial change the answer?

0:00 – The trio everyone's told to take together

1:09 – The magnesium story

2:47 – Why K2 is different

3:45 – Putting it to the test

4:15 – What the trials found

5:55 – What you should actually do

6:40 – K2: cutting through the hype

7:06 – When it makes sense, when it doesn't

For most of the last century, apigenin was a footnote — a yellow pigment in chamomile and parsley, studied mostly by people cataloguing the antioxidants in plants. In the last few years it has become one of the most-recommended compounds on the internet: the third ingredient in the famous sleep stack, a fixture in longevity protocols built around NAD+, and an addition to formulas aimed at cellular aging itself. But how does the evidence hold up?

0:00 - Introduction

0:45 - Why apigenin is everywhere right now

2:30 - How apigenin works

4:30 - Human anxiety trials

6:00 - Second discovery

8:00 - What the marketing gets wrong

10:45 - Where the evidence actually stands

12:20 - Should you take it?

For decades, magnesium sat in the supplement aisle as a mineral for muscle cramps, sleep, and general nutrition. Around 2010, that changed. A branded form called magnesium L-threonate launched on the back of a 2010 MIT rodent paper, and a new category was born — magnesium for the brain. Fifteen years later, that category has expanded to include other brand-targeted forms, premium price points, and confident claims about cognition, memory, and synaptic density. In this investigation, we review the science underneath those claims.

IN THIS INVESTIGATION

• What two papers from 1984 actually said about magnesium and the brain
• Why magnesium concentrates differently in brain fluid than in blood, and what that implies for supplementation
• The 2010 MIT paper that launched the brand-targeted magnesium category, and the question it didn't answer
• What you find when you trace the authorship of the rodent studies that "independently confirmed" the original
• The magnesium acetyl taurate line and what a 2026 head-to-head comparison reveals about form-specific brain delivery
• Every human trial on magnesium L-threonate, who funded each one, and the structural feature they all share
• The 2024 paper that directly measured magnesium inside living human brains for the first time in twenty-five years
• What the ordinary forms — citrate, chloride, oxide — have actually demonstrated in independent human trials
• Why a failed 2007 traumatic brain injury trial matters for everything that followed
• The single piece of evidence the brand-targeted magnesium story has never produced
• What to do if you take magnesium for cognitive reasons

Subscribe for more investigations.